Merck in Talks to Acquire Drug Maker Cubist for More Than $7 Billion – NYTimes.com
1
Merck & Company, the big drug maker, is in talks to acquire the biopharmaceuticals company Cubist for more than $7 billion, according to people briefed on the matter.
The deal, if announced, would represent another multibillion-dollar health care transaction in a banner year for mergers and acquisitions in the industry.
Read more – NYTimes.com
One thought on “Merck in Talks to Acquire Drug Maker Cubist for More Than $7 Billion – NYTimes.com”
Leave a Reply
You must be logged in to post a comment.
Hopefully this will not result in even further job losses in the pharma industry…